The Platelet Aggregation Devices Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for platelet aggregation devices has seen substantial growth recently. Its rise from $0.83 billion in 2024 to $1.05 billion in 2025 represents a Compound Annual Growth Rate (CAGR) of 25.8%.
In 2029, the market size for platelet aggregation devices is anticipated to reach $2.59 billion, experiencing a compound annual growth rate (CAGR) of 25.4%.
Download Your Free Sample of the 2025 Platelet Aggregation Devices Market Report and Uncover Key Trends Now!The drivers in the platelet aggregation devices market are:
• Rising prevalence of cardiovascular diseases
• Increased instances of bleeding disorders
• Increased awareness regarding health diagnostics
• Growth in the number of surgical procedures.
The platelet aggregation devices market covered in this report is segmented –
1) By Product: Reagents, Systems, Consumables And Accessories
2) By Type: Four Channel, Dual Channel, Eight Channel
3) By Technology: Optical, Impedance, Other Technologies
4) By Application: Clinical Applications, Research Applications, Cardiovascular Applications, Orthopedic Applications, Other Applications
5) By End-User: Standalone Hospitals, Diagnostic Laboratories, Research And Academic Institutes, Other End Users
The trends in the platelet aggregation devices market are:
• The integration of artificial intelligence in diagnostics is a key emerging trend.
• The development of portable platelet aggregation devices is shaping the future of the market.
• Increased collaboration between biotech firms and healthcare providers is an emerging trend.
• A shift towards home-based diagnostics is gaining momentum in this market.
The major players in the platelet aggregation devices market are:
• Roche Holding AG
• Cytiva (Danaher Corp)
North America was the largest region in the platelet aggregation devices market in 2023